Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
REGEnLIFE cures inflammatory brain diseases with light
Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases
Boost Invest MedVallée: a decisive springboard for Montpellier’s global healthcare startups

Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease

Clinical Trials on Alzheimer’s Disease Asia (CTAD Asia) 2019, Beijing

Guillaume Blivet, Laura Auboyer, Johann Meunier, François J. Roman, Jacques Touchon.

Share this article